Роль неоадъювантной гормонотерапии в лечении рака молочной железы: что мы знаем на данный момент?В. В. Воротников,
V. V. Vorotnikov,
Р. А. Пахомова,
R. A. Pakhomova,
А. В. Сойнов,
A. V. Soinov,
А. С. Гунина,
A. S. Gunina,
И. В. Копытич,
I. V. Kopytich,
М. Г. Цой,
M. G. Tsoi,
С. А. Абдугаффоров,
S. A. Abdugafforov (Креативная хирургия и онкология, №3, 2022) Preoperative Hormone Therapy in the Treatment of
Breast Cancer: What Do We Know So Far?
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) involved in the
disease. As a result of previous exome sequencing of DNA samples from
breast cancer Germany
Dzhaubermezov, M.,
Ekomasova, N.,
Mustafin, R.,
Gabidullina, L.,
Galimova, Y.,
Nurgalieva, A.,
Valova, Y.,
Prokofyeva, D.,
Khusnutdinova, E. (2022) , colorectal cancer,
breast cancer, and cervical cancer. Genotyping was
performed on 540 supposedly healthy
Sufianova, Galina,
Sufianova, Galina,
Beylerli, Ozal,
Wu, Jianing,
Shumadalova, Alina,
Sufianov, Albert,
Chen, Xin,
Zhao, Shiguang (2022) inflammatory process increases the risk of developing sarcoma, melanoma, and
breast, lung, liver, and prostate